Hyperphosphatemia is a common complication in patients with chronic kidney disease
(CKD), particularly in those requiring renal replacement therapy. The importance of …

Calcium, phosphorus, and magnesium homeostasis is altered in chronic kidney disease
(CKD). Hypocalcemia, hyperphosphatemia, and hypermagnesemia are not seen until …

Although previous studies in the general population showed that hypomagnesemia is a risk
for cardiovascular diseases (CVD), the impact of magnesium on the prognosis of patients on …

Although the following text will focus on magnesium in disease, its role in healthy subjects
during physical exercise when used as a supplement to enhance performance is also …

Background Vascular calcification (VC) is prevalent in patients suffering from chronic kidney
disease. Factors promoting calcification include abnormalities in mineral metabolism …

Objectives: The aim of this study was to examine whether magnesium intake is associated
with coronary artery calcification (CAC) and abdominal aortic calcification (AAC) …

Over the last decade, an increasing number of studies report a close relationship between
serum magnesium concentration and cardiovascular disease risk in the general population …

Background Previous studies reported that magnesium deficiency was associated with
vascular calcifications, atherosclerosis and cardiovascular disease, which might play an …

Decreased bone mass and an increased risk of bone fractures become more common with
age. This condition is often associated with osteoporosis and is caused by an imbalance of …

Abstract Background Hypomagnesemia (plasma magnesium (Mg2+) concentration< 0.7
mmol/L) has been described in patients with type 2 diabetes. Polypharmacy is inevitable …